The Latest Research, Commentary, And News From Health Affairs
Tuesday, December 28, 2021
Dear John,
Late 2021 marked the first anniversary for our podcast program.
To celebrate and give you something to listen to over the extended weekend, we want to highlight the year’s most listened to podcasts from Health Affairs.
A Health Podyssey: Ashish Jha In November, Ashish Jha from the Brown School of Public Health joined Health Affairs Editor-in-Chief and A Health Podyssey host Alan Weil to discuss what he’s learned from the COVID-19 pandemic and the bright spots he sees for health care payment reform. Don’t miss this insightful conversation between seasoned health policy professionals.
A Health Podyssey: Leemore Dafny Many of the popular A Health Podyssey episodes focus on the business of health care or drug markets. This September episode features a wide-ranging conversion with Harvard Business School’s Leemore Dafny highlighting her
research on hospital prices and market concentration.
Health Affairs This Week: Breaking Down The 2021 Momnibus Bill The Health Affairs This Week podcast focuses on the biggest news that catches the attention of the Health Affairs editorial team. In February Senior Editors Jessica Bylander and Leslie Erdelack published an explainer on the 2021 Momnibus Bill. Listeners kept coming back to the episode throughout the year to understand the bill and its implications.
A Health Podyssey: LIVE with Liz Fowler Health Affairs launched a series of free virtual events in 2021 (you can view the upcoming schedule and register for an event here). As part of our Policy Spotlight series, Alan Weil spoke in June with Liz Fowler, director of the Center for Medicare and Medicaid
Innovation, about President Biden’s health care agenda.
A Health
Podyssey: Leah Rand As a measure used in value assessment, the quality-adjusted life-year (or QALY) has received a lot of criticism. Leah Rand, a postdoctoral fellow at Harvard Medical School and Brigham and Women’s Hospital, came on A Health Podyssey in September to explore the strengths and weaknesses of those critical arguments. Ultimately, she argued, the QALY is essential for the move to value-based pricing.
A Health Podyssey: Scott Howell Drug prices and spending are a big concern. Some estimates put spending on prescription drugs in the US at more than $500 billion per year. Novartis Pharmaceuticals Chief Strategy Officer Scott Howell joined A Health Podyssey to discuss the large costs of drug utilization management and what can be done about them.
A Health Podyssey: Sabrina Poon Under the “two midnight rule,” hospitals are only paid inpatient rates for those patients expected to stay in the hospital over two nights. Sabrina Poon from the Vanderbilt University Medical Center came on A Health Podyssey to speak about how that controversial rule has affected inpatient admissions and outpatient stays.
A Health Podyssey: Ariel Dora Stern In another drug markets–focused episode Ariel Dora Stern explains how quickly biosimilars and follow-on products gained market share and the subsequent trajectory of drug prices. For any scholars of evolving health product markets, this episode is for you.
Finally, on this October episode of Health Affairs This Week, Deputy Editor Rob Lott dives into his secret love of urban planning and explores a Health Policy Brief by Michael Lens from the University of California Los Angeles. Lens discusses how low-density zoning relates to health and health equity.
Health Affairs is the leading peer-reviewedjournalat the intersection of health, health care, and policy. Published monthly by Project HOPE, the journal is available in print and online. Late-breaking content is also found through healthaffairs.org, Health Affairs Today, and Health Affairs Sunday Update.
Project HOPE is a global health and humanitarian relief organization that places power in the hands of local health care workers to save lives across the globe. Project HOPE has published Health Affairs since 1981.
